SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-05-000896
Filing Date
2005-03-07
Accepted
2005-03-04 17:40:50
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w06191e10vk.htm 10-K 1189407
2 EX-10.30A w06191exv10w30a.htm EX-10.30A 147076
3 EX-10.30B w06191exv10w30b.htm EX-10.30B 29156
4 EX-10.30C w06191exv10w30c.htm EX-10.30C 25416
5 EX-10.30D w06191exv10w30d.htm EX-10.30D 34076
6 EX-21.01 w06191exv21w01.htm EX-21.01 3276
7 EX-23.01 w06191exv23w01.htm EX-23.01 2019
8 EX-31.01 w06191exv31w01.htm EX-31.01 6561
9 EX-31.02 w06191exv31w02.htm EX-31.02 6632
10 EX-32.01 w06191exv32w01.htm EX-32.01 1985
11 EX-32.02 w06191exv32w02.htm EX-32.02 2124
  Complete submission text file 0000950133-05-000896.txt   1450301
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 05662249
SIC: 2834 Pharmaceutical Preparations